Choroidal Neovascularization - 25 Studies Found
Completed |
: Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial : Choroidal Neovascularization : 2006-08-09 :
|
Completed |
: Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen : Choroidal Neovascularisation : 2009-12-21 : Drug: ranibizumab 0.5mg |
Recruiting |
: Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization : Choroidal Neovascularization : 2014-10-06 : Drug: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321) Administration by intravitreal injection |
Recruiting |
: Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization : Choroidal Neovascularization : 2016-08-21 : Drug: 0.5mg intravitreal ranibizumab Patients received ranibizumab (0.5mg, Novartis AG, Basel, Switzerla |
Completed |
: Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE) : Choroidal Neovascularization : 2007-08-01 : Drug: Intravitreal injection ranibizumab Monthly intravitreal injection of 0.5mg ranibizumab in one eye |
Recruiting |
: Intravitreal Conbercept for Idiopathic Choroidal Neovascularization : Idiopathic Choroidal Neovascularization : 2016-07-27 : Drug: conbercept 0.05ml conbercept Other Name: conbe |
Recruiting |
: Efficacy of Aflibercept (Eylea®) on Choroidal Neovascularization (Type 3) : Type 3 Choroidal Neovascularization : 2014-12-10 : Drug: Aflibercept |
Recruiting |
: TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration : Choroidal Neovascularization : 2005-11-29 : Procedure: Photodynamic therapy versus Transpupillary thermotherapy |
Completed |
: Bevacizumab Intravitreal for Myopic Choroidal Neovascularization : Myopic Choroidal Neovascularization : 2008-11-24 : Drug: Injection Intravitreal injection of 1.25 mg bevacizumab |
Withdrawn |
: Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration : Choroidal Neovascularization : 2006-11-22 : Drug: Imatinib Mesylate /Ranibizumab |